CV/COS Webinar: Clip 16
During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.